Back to search
FDAFDA · Food and drugs·Recall number Z-0093-2025

Beckman Coulter IRISPEC CA/CB/CC Urine Chemistry Controls, Catalog Number REF 800-7211 and 800-7702, in vitro diagnostic device.

Published October 23, 2024 · Recall initiated: July 16, 2024

Summary

FDA records medical device Class III recall Z-0093-2025, published October 23, 2024 and initiated July 16, 2024. Recalling firm: Beckman Coulter, Inc.; Status: Ongoing; Reported quantity: 5589 units; Lot: UDI/DI 10837461002611, Lot Numbers: 432-24 and higher. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Beckman Coulter has become aware of an increase in customer complaints for intermittent IRISpec CB negative glucose control failure, resulting in false positive control results when used in conjunction with iChemVELOCITY Urine Chemistry Strips (PNs 800-7204 and 800-7212) on the iChemVELOCITY Analyzer. This issue may delay the reporting of patient results, with a worst-case scenario of a delay in diagnosis or treatment of metabolic disorders, kidney function abnormalities, urinary tract infections, and liver function.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Beckman Coulter, Inc.
Distributor
worldwide
Lot
UDI/DI 10837461002611, Lot Numbers: 432-24 and higher
Risk classification
Class III
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Beckman Coulter IRISPEC CA/CB/CC Urine Chemistry Controls, Catalog Number REF 800-7211 and 800-7702, in vitro diagnostic device. recalled?

Yes. FDA published recall Z-0093-2025 on October 23, 2024. Reported hazard: Beckman Coulter has become aware of an increase in customer complaints for intermittent IRISpec CB negative glucose control failure, resulting in false positive control results when used in conjunction with iChemVELOCITY Urine Chemistry Strips (PNs 800-7204 and 800-7212) on the iChemVELOCITY Analyzer. This issue may delay the reporting of patient results, with a worst-case scenario of a delay in diagnosis or treatment of metabolic disorders, kidney function abnormalities, urinary tract infections, and liver function.

What should I do if I have this product?

Voluntary: Firm initiated · Letter